Bombyx mori F7 variety drug-resistant BmCXE-26 gene as well as regulatory sequence and application thereof

By cloning and upregulating the BmCXE-26 gene and its regulatory sequence in the F7 silkworm variety, the tolerance of silkworms to pyrethroid insecticides was significantly improved, solving the problem of silkworm sensitivity to pyrethroid insecticides. This provides targets and molecular markers for molecular breeding and enhances the ability to control agricultural pests.

CN119040336APending Publication Date: 2024-11-29JIANGSU UNIV OF SCI & TECH +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411245851.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-06
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

Silkworms are sensitive to pyrethroid insecticides, which affects their growth and development. Existing technologies are insufficient to effectively improve their tolerance to pyrethroid insecticides.

Method used

We provide the BmCXE-26 gene and its regulatory sequence for insecticide resistance in the F7 silkworm variety. By significantly upregulating gene expression levels, we enhance the silkworm's tolerance to pyrethroid insecticides.

Benefits of technology

It significantly improved the tolerance of silkworms to pyrethroid insecticides, enhanced their resistance, provided targets and molecular markers for molecular breeding, and guided agricultural pest control.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119040336A_ABST
    Figure CN119040336A_ABST
Patent Text Reader

Abstract

The invention discloses a bombyx mori F7 variety drug-resistant BmCXE-26 gene as well as a regulatory sequence and application thereof. An amino acid sequence coded by the gene is shown as SEQ ID NO: 1. The bombyx mori F7 variety BmCXE-26 gene has the advantages that (1) the regulatory sequence of the bombyx mori F7 variety BmCXE-26 gene can obviously up-regulate the expression level of the gene; (2) the bombyx mori F7 variety BmCXE-26 gene and the regulatory sequence of the bombyx mori F7 variety BmCXE-26 gene can be used as a molecular marker of a bombyx mori anti-pyrethroid insecticide, or can be used as a target of molecular breeding; (3) a transcription element, an expression vector and a host cell containing the gene and a regulatory sequence thereof, and even a heterozygote also have a high expression level of the BmCXE-26 gene; and (4) the gene and the regulatory sequence thereof provide guidance for pest control in agricultural production from a new perspective.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of molecular breeding, and relates to the application of a functional gene and its regulatory sequence in molecular breeding of silkworm resistance to pyrethroid insecticides, specifically the BmCXE-26 gene of silkworm F7 variety resistance, its regulatory sequence and application. Background Art

[0002] Silkworms are extremely sensitive to adverse environments such as pesticides and viruses. Mulberry gardens are usually geographically adjacent to traditional agricultural cash crops (grains, vegetables and fruits), so they are often affected by pesticide drift, resulting in pesticide residues on mulberry leaves. Silkworms that eat contaminated mulberry leaves will have their normal growth and development affected. In mild cases, they will form thin cocoons or no cocoons after mating, and in severe cases, they will die in the larval stage, causing great economic losses to silkworm farmers.

[0003] In agricultural management activities, pyrethroid insecticides are widely used due to their broad spectrum and economic efficiency. In order to improve the insecticidal efficiency of pesticides, pyrethroid hyperosmotic agents are often added to other types of pesticides, so pyrethroid insecticides have become one of the main culprits of mulberry garden pesticide pollution. In addition, due to the global ban or restriction of organophosphorus pesticides and the expiration of the patent for deltamethrin pesticides, pyrethroid pesticides represented by deltamethrin are widely used.

[0004] The preliminary experiments of this research group have clarified the mechanism of silkworm resistance to pyrethroids, and screened and cultivated practical silkworm varieties that are resistant to pyrethroid insecticides. A screening test for pyrethroid pesticide resistance was conducted on 160 silkworm seed resources, and the silkworm variety F7 was obtained, whose tolerance to pyrethroid pesticides is 100-120 times higher than that of conventional varieties. Moreover, the resistance of the silkworm variety F7 to pyrethroid pesticides can be inherited, which is a good material for studying the resistance mechanism of silkworms to pyrethroid pesticides and cultivating pesticide-resistant silkworm varieties. In the prior art, studies on the mechanism of drug resistance have shown that metabolic resistance is one of the main mechanisms of silkworm resistance to pyrethroid insecticides. Esterase, as the main metabolic detoxification enzyme, acts on the ester bond of pyrethroid insecticides to hydrolyze them into acids and alcohols. This esterase-catalyzed degradation process is the main form of tolerance and detoxification of pyrethroid insecticides by living organisms, and can effectively degrade pyrethroid insecticides. Therefore, esterase plays an important role in the degradation of pyrethroid insecticides. Summary of the invention

[0005] Technical problem to be solved: In order to overcome the shortcomings of the prior art, a functional gene capable of resisting pyrethroid pesticides is provided, and the expression level of the gene is improved, so as to better exert the function of the gene and achieve high tolerance of silkworms to pyrethroid insecticides; in view of this, the present invention provides the silkworm F7 variety drug-resistant BmCXE-26 gene, its regulatory sequence and application.

[0006] Technical solution: The drug-resistant BmCXE-26 gene of the silkworm F7 variety, the amino acid sequence encoded by the gene is shown in SEQ ID NO: 1; wherein the sequence of SEQ ID NO: 1 is as follows:

[0007] MSLTHVEQGTLDGVVCDNGKYVAFKGIPYAKPPLGKLRFKAPEPPETWDGIRNANEHGPI

[0008] CPQYNERMNRIEDGSEDCLYLNVYSKNLKPTTPLPVMVWIHGGGFYTGSGNSEFYGPDFF

[0009] MEHEVILVTLNYRLEVLGFLCLDNEEVPGNAGLKDQVAALKWIKQNIAAFGGDKNNITLF

[0010] GCSAGSASTSLHLVSDMSKGLFDKAICQSGVCLNEWAYNLYARERAFQLGKLLGKETEDE

[0011] IELLEFLRSIPASSLVNNELPYLQINNIDLVDNIKFGPVIENPNLNVEKFLKESPVNLVKKGHL

[0012] ANIPLILGYTSGEAIEIVRNLPRIVNYYSMVGSVVPRELKLKLQLEDIKELDVKIRKHYCGGK

[0013] EITQDMYQELVDLETDRLFVYNIIRYARYHNHHNSKPVFLYKFTAETERNYTKRNYNMNT

[0014] VKGVCHSDDLMYFFNVTCLDIRLTQESKDIIDKLVRLWVNFAKTG*.

[0015] Preferably, the nucleotide sequence encoded by the gene is shown in SEQ ID NO: 2; the sequence of SEQ ID NO: 2 (i.e., the full-length CDS sequence of the BmCXE-26 gene) is as follows:

[0016] ATGTCTTTGACTCACGTCGAACAAGGAACACTGGATGGCGTTGTTTGTGATAATGGAA

[0017] AATACGTGGCGTTTAAAGGAATACCATATGCTAAACCACCACTCGGAAAATTAAGATT

[0018] CAAAGCCCCAGAACCACCTGAAACTTGGGACGGTATCAGAAATGCTAACGAACACGG

[0019] CCCAATATGTCCACAATACAACGAAAGAATGAACAGAATCGAAGATGGGAGTGAAGA

[0020] TTGTCTCTATCTCAACGTGTATTCTAAAAATCTGAAACCGACCACACCTCTTCCAGTCA

[0021] TGGTTTGGATACATGGTGGAGGTTTCTATACGGGATCGGGAAACTCTGAATTTTATGGG

[0022] CCAGATTTTTTCATGGAACATGAGGTAATACTCGTGACACTTAACTACAGACTAGAAGT

[0023] TCTAGGGTTCTTGTGTCTAGACAATGAAGAAGTTCCAGGAAACGCTGGGCTCAAAGAT

[0024] CAAGTGGCCGCTTTGAAGTGGATTAAACAAAATATCGCTGCATTCGGGGGAGACAAAA

[0025] ACAATATTACACTTTTTGGGTGCAGTGCAGGGTCGGCCTCAACATCTCTGCATTTAGTA

[0026] TCCGATATGAGCAAAGGACTATTCGACAAAGCCATTTGTCAAAGTGGTGTTTGTTTAAA

[0027] TGAATGGGCATACAATTTATATGCACGCGAAAGAGCCTTCCAGTTGGGTAAACTCTTG

[0028] GGGAAAGAAACTGAAGACGAAATTGAATTACTAGAATTTTTAAGAAGCATTCCTGCTT

[0029] CTTCGCTTGTCAACAACGAACTGCCATATCTTCAAATAAATAACATAGATTTAGTAGAC

[0030] AATATAAAGTTCGGACCGGTAATAGAAAATCCAAATCTCAATGTTGAAAAGTTTCTCA

[0031] AGGAATCACCGGTTAACTTAGTTAAAAGGACATTTGGCAAATATACCCCTAATTTT

[0032] GGGATACACCTCAGGGGAAGCAATAGAAATTGTCAGAAACCTTCCCCGTATTGTCAAT

[0033] TACTATTCAATGGTAGGGAGCGTCGTGCCACGGGAATTAAAATTGAAATTGCAATTGG

[0034] AAGATATAAAGGAATTGGATGTAAAAATAAGAAAACATTACTGTGGAGGCAAAGAAA

[0035] TTACTCAAGACATGTATCAAGAATTGGTGGATTTAGAAACAGATCGCCTTTTCGTGTAT

[0036] AACATCATTAGGTATGCGAGGTATCACAACCATCATAATTCAAACCCGTGTTCTTATA

[0037] CAAGTTCACTGCCGAAACCGAACGAAATTATACTAAAAGGAATTACAACATGAATACA

[0038] GTAAAAGGAGTCTGCCATTCTGATGATTTAATGTATTTTTTCAATGTCACTTGTCTCGAC

[0039] ATACGTCTCACACAAGAATCTAAAGACATAATCGACAAATTGGTACGCTTGTGGGTCAATTTTGCAAAAACAGGGTAA。

[0040]

[0041] Furthermore, the regulatory sequence of the gene is cloned by the following steps: amplification is performed using the silkworm egg genome of the silkworm F7 variety as a template, wherein the forward primer is such as SEQ ID NO: 6, 5'-GAAAGAAAACGGAGCTCTAAC-3', and the reverse primer is such as SEQ ID NO: 7, 5'-GATTCGCTTTTCAAACGGTG-3'.

[0042] Preferably, the regulatory sequence is used to significantly upregulate the expression of the drug-resistant BmCXE-26 gene in the silkworm F7 variety.

[0043] The method for synthesizing the drug-resistant BmCXE-26 gene of any of the above-mentioned silkworm F7 varieties comprises the following steps:

[0044] S1, midgut tissue of 5-year-old 3-day-old silkworm F7 strain was obtained, total RNA was extracted, and then total RNA was used as a template for reverse transcription to synthesize cDNA;

[0045] S2. The CDS sequence of the BmCXE-26 gene was synthesized using cDNA as a template, wherein the forward primer for cloning the CDS sequence was such as SEQ ID NO: 4, 5'-ATGTCTTTGACTCACGTC-3', and the reverse primer was such as SEQ ID NO: 5, 5'-TTACCCTGTTTTTGCAAAATTGA-3'.

[0046] The use of any of the above-mentioned BmCXE-26 genes and their regulatory sequences as molecular markers for silkworm resistance to pyrethroid insecticides.

[0047] The use of any of the above-mentioned BmCXE-26 genes and their regulatory sequences as molecular breeding targets for silkworm resistance to pyrethroid insecticides.

[0048] An expression vector comprising any of the above-mentioned BmCXE-26 genes and its regulatory sequences.

[0049] A host cell comprising the above-mentioned expression vector.

[0050] Beneficial effects: (1) The regulatory sequence of the BmCXE-26 gene of the silkworm F7 variety described in the present invention can significantly increase the expression level of the gene; (2) The BmCXE-26 gene of the silkworm F7 variety described in the present invention and its regulatory sequence can be used as a molecular marker for silkworm resistance to pyrethroid insecticides, or as a target for molecular breeding; (3) The transcription elements, expression vectors and host cells containing the gene and its regulatory sequence, and even the hybrids, also have a high expression level of the BmCXE-26 gene; (4) The gene and its regulatory sequence provide guidance for pest control in agricultural production from a new perspective. BRIEF DESCRIPTION OF THE DRAWINGS

[0051] Figure 1 This is a comparative analysis of the amino acid sequences encoded by the silkworm F7 and Dazao BmCXE-26 genes.

[0052] Figure 2 This is a comparison analysis of the CDS sequences of the silkworm F7 and Dazao BmCXE-26 genes.

[0053] Figure 3 This is a comparison analysis of the gene regulatory sequences of silkworm F7 and Dazao BmCXE-26.

[0054] Figure 4 The results are as follows: The transcription level of BmCXE-26 gene in the midgut tissue of silkworm F7 fed with 0.1 mg / L deltamethrin; the differences are represented by *(p<0.05), ***(p<0.001).

[0055] Figure 5 It is the RT-PCR electrophoresis diagram of the existence form of the regulatory sequence of BmCXE-26 gene between the silkworm F7 variety and other varieties;

[0056] Among them, M is 2000Maker; 1 is F7; 2 is Dazao; 3 is C108; 4 is Su12; 5 is A1; 6 is A3; 7 is Euro16; 8 is Ri120; 9 is 7532; 10 is 784; 11 is 317; 12 is 318; 13 is 871; 14 is 872; 15 is Fengyi; 16 is 54A; 17 is YeA; 18 is YeB; 19 is 84Y2; 20 is YeAN; 21 is YeBN; 22 is C.

[0057] Figure 6 It is the RT-PCR electrophoresis diagram of the nucleic acid molecule of the present invention between the silkworm F7 and the varieties introduced after hybridization with the F7 bloodline;

[0058] Among them, M is 2000Maker; 1 is F7; 2 is F7×DaZao; 3 is F7×C108; 4 is F7×Su12; 5 is F7×A1; 6 is F7×A3; 7 is F7×Ou16; 8 is F7×Ri120; 9 is F7×7532; 10 is F7×784; 11 is F7×317; 12 is F7×318; 13 is F7×871; 14 is F7×872; 15 is F7×Fengyi; 16 is F7×54A; 17 is F7×YeA; 18 is F7×YeB; 19 is F7×84Y2; 20 is F7×YeAN; 21 is F7×YeBN; 22 is F7×C.

[0059] Figure 7This is a graph showing the transcriptional activity of the regulatory sequence of the present invention and other varieties of regulatory sequences; wherein the difference is indicated by **** (p<0.0001). DETAILED DESCRIPTION

[0060] The following examples further illustrate the content of the present invention, but should not be construed as limiting the present invention. Without departing from the spirit and essence of the present invention, modifications and substitutions made to the method, steps or conditions of the present invention all belong to the scope of the present invention. Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art.

[0061] It is well known to those skilled in the art that the silkworm F7 variety has a strong resistance to pyrethroid insecticides.

[0062] Example 1 Cloning of the CDS sequence of the silkworm F7 variety BmCXE-26 gene and the nucleic acid sequence of the present invention

[0063] According to the BmCXE-26 gene sequence included in the SilkDB3.0 database, specific primers for cloning the CDS sequence of the gene were designed, specifically: CDS sequence cloning forward primer F (SEQ ID NO: 4): 5'-ATGTCTTTGACTCACGTC-3', CDS sequence cloning reverse primer R (SEQ ID NO: 5): 5'-TTACCCTGTTTTTGCAAAATTGA-3'. In addition, specific primers for cloning the gene expression regulatory sequence were designed, specifically: forward primer F (SEQ ID NO: 6): 5'-GAAAGAAAACGGAGCTCTAAC-3', reverse primer R (SEQ ID NO: 7): 5'-GATTCGCTTTTCAAACGGTG-3'.

[0064] CDS sequence amplification (SEQ ID NO: 2) was performed using the cDNA template of the midgut of the fifth instar and third day of silkworm F7, and the nucleic acid sequence (SEQ ID NO: 3) was amplified using the silkworm F7 silkworm egg genome, and DaZao was used as the control group. According to the TA cloning method, the PCR product was recovered and connected to the pMD19-T vector, and then transformed into DH5α competent cells, and the positive clones were sent to Zhejiang Shangya Biotechnology Co., Ltd. for sequencing. Among them, the PCR reaction conditions were: 94℃ pre-denaturation for 5 minutes, then 94℃ denaturation for 30 seconds, 58℃ annealing for 30 seconds, 72℃ extension for 1min30 seconds, a total of 35 cycles, and finally 72℃ extension for 10 minutes.

[0065] Sequencing and bioinformatics analysis showed that: Figure 2 , 3As shown, the CDS sequence of the BmCXE-26 gene is 1419 bp in size, and the regulatory sequence is 1285 bp in size. Compared with the CDS sequence of the BmCXE-26 gene of the silkworm F7 variety, the CDS sequence of the BmCXE-26 gene of the silkworm F7 variety has 11 nucleotide base site mutations and 5 amino acid site mutations. The regulatory sequence of the BmCXE-26 gene of the silkworm F7 variety has a continuous large fragment deletion of 715 bp in size.

[0066] Example 2 qPCR detection of BmCXE-26 gene transcription level in the midgut of silkworm F7 fed with 0.1 mg / L deltamethrin

[0067] The silkworm F7 fed with 0.1 mg / L deltamethrin was the treatment group, and the silkworm F7 fed with ultrapure water was the control group. The midgut cDNA collected 6, 12, 18 and 24 h after feeding with 0.1 mg / L deltamethrin was used as a template, and the fluorescent quantitative specific primers BmCXE-26-qRT-F (SEQ ID NO: 8): 5'-AACAGATCGCCTTTTCGTGT-3', BmCXE-26-qRT-R (SEQ ID NO: 9): 5'-TGTGTGAGAGGTATGTCGAGA-3' of the silkworm F7 BmCXE-26; the forward primer F (SEQ ID NO: 10): 5'-CATTCCGCGTCCCTGTTGCTAAT-3', the reverse primer R (SEQ ID NO: 11): 5'-GCTGCCTCCTTGACCTTTTGC-3' of the internal reference gene BmGAPDH were used for qPCR detection. The overall experimental process was carried out according to the instructions for use of the instrument and the kit (TRUEscript RT MasterMIX, Beijing Aidelai Biotechnology Co., Ltd.).

[0068] like Figure 4 As shown, the results of qPCR showed that the expression of BmCXE-26 gene was significantly upregulated at all time points in the midgut tissue of silkworm F7 after feeding 0.1 mg / L cypermethrin.

[0069] Example 3 Analysis of genomic molecular markers among silkworm varieties and evaluation of drug resistance after introduction of F7 lineage

[0070] Among 21 germplasm resources of silkworm purebred Dazao and Su 12, RT-PCR results showed that ( Figure 5 ), the genomic molecular markers all exist in the form of complete large fragments; after hybridization and introduction into the F7 lineage ( Figure 6), all of which exist in heterozygous form (i.e., there are complete large fragments and missing small fragments). 21 pure strains and hybrids introduced with F7 bloodline were raised in normal mulberry leaves, and the second-instar silkworms were fed with 0.1 mg / L deltamethrin (60 heads / group, 3 replicates). The results showed that the survival rate was significantly improved after the introduction of F7 bloodline, indicating that the BmCXE-26 gene of the silkworm F7 variety is a dominant resistance gene.

[0071] The survival rates of silkworm F7, other silkworm varieties, and hybridization of F7 and other silkworm varieties were compared 24 hours after feeding with 0.1 mg / L cypermethrin, as shown in Table 1.

[0072] Table 1 Determination of the survival rate of silkworm F7 and other silkworm species after 24h treatment with cypermethrin

[0073]

[0074] Example 4 Analysis of luciferase activity of two forms of transcription elements in BmN cell line

[0075] In order to further determine whether the deletion of 715bp of the regulatory sequence of the silkworm BmCXE-26 gene affects the promoter activity of the gene, the present embodiment constructs the reporter vectors pGL3-F7 (a small fragment of the deleted type) and pGL3-D (a large fragment of the complete type) of two regulatory sequences. The positive clones are then screened and sequenced. After the sequencing is correct, the analysis is performed according to cell transfection and transient expression activity determination. Finally, the activation efficiency is analyzed, and the results show that the transcription and activation efficiency of the deleted small fragment sequence is significantly higher than that of the complete large fragment (3.7 times).

[0076] like Figure 7 As shown in the figure, the luciferase activity of the pGL3-F7 type promoter reporter vector is significantly higher than that of the pGL3-D gene type, indicating that the deletion of the 715bp regulatory sequence region of the silkworm BmCXE-26 gene enhances the transcriptional expression of the gene in the silkworm F7 variety by affecting the promoter activity, thereby improving the drug resistance of the silkworm F7. The deletion of the BmCXE-26 gene expression regulatory sequence improves the expression efficiency of the gene, thereby obtaining the ability to resist pyrethroid insecticides. As a key gene for the resistance of the silkworm F7 variety to pyrethroid insecticides, the BmCXE-26 gene can be used as a target gene for molecular breeding of silkworm pesticide resistance. Therefore, the silkworm F7 variety can be used as a material, hybridized and introduced into practical varieties, and then through methods such as genomic molecular marker screening and pesticide investigation, new silkworm varieties with resistance to pyrethroid pesticides can be efficiently cultivated, which has important theoretical value and practical significance for application in sericulture production.

[0077] In summary, the present invention successfully cloned and analyzed the CDS sequence and regulatory sequence of the key gene BmCXE-26 of the silkworm F7 variety resistant to pyrethroid insecticides, and the cloning process was very difficult. Through the analysis of sequencing results, it was found that the CDS sequence of the silkworm F7 variety BmCXE-26 had 11 base site mutations and 5 amino acid site mutations; there was a continuous large fragment deletion of 715bp in the regulatory sequence. Further analysis using qPCR technology showed that the silkworm F7 variety BmCXE-26 showed a significant up-regulated expression after adding 0.1 mg / L of deltamethrin, indicating that BmCXE-26 is related to the resistance of silkworm F7 to pyrethroid insecticides. The survival rate of the second-instar silkworms fed with 0.1 mg / L deltamethrin was investigated by 21 germplasm resources and hybrids with F7 bloodlines introduced into 21 germplasm resources. The results showed that the survival rate of the hybrids was significantly higher than that of the control group. The results of RT-PCR using genomic DNA as a template showed that in all 21 germplasm resources, the gene was present in the form of a complete large fragment, and the corresponding heterozygous lines after the introduction of the F7 lineage all existed in a heterozygous form (i.e., there were complete large fragments and missing small fragments). The results showed that the silkworm F7 variety BmCXE-26 was a dominant resistance gene. The results of the dual fluorescence reporter test confirmed that the transcription and initiation expression efficiency of the missing small fragment sequence was significantly higher than that of the complete large fragment. Therefore, the silkworm F7 variety BmCXE-26 gene is of great value in the breeding of new silkworm varieties resistant to pyrethroid pesticides.

Claims

1. The drug-resistant BmCXE-26 gene of silkworm F7 variety, characterized in that: The amino acid sequence encoded by the gene is shown in SEQ ID NO:

1.

2. The silkworm F7 variety drug resistance BmCXE-26 gene according to claim 1, characterized in that: The nucleotide sequence encoded by the gene is shown in SEQ ID NO:

2.

3. The silkworm F7 variety drug resistance BmCXE-26 gene according to claim 1, characterized in that: The regulatory sequence of the gene is shown in SEQ ID NO:

3.

4. The silkworm F7 variety drug resistance BmCXE-26 gene according to claim 3, characterized in that: The regulatory sequence of the gene is cloned by the following steps: amplification is performed using the silkworm egg genome of the silkworm F7 variety as a template, wherein the forward primer is shown in SEQ ID NO:6, and the reverse primer is shown in SEQ ID NO:

7.

5. The drug-resistant BmCXE-26 gene of silkworm F7 variety according to claim 3, characterized in that: The regulatory sequence is used in significantly up-regulating the expression of the drug-resistant BmCXE-26 gene of the silkworm F7 variety.

6. A method for synthesizing the drug-resistant BmCXE-26 gene of the silkworm F7 variety according to any one of claims 1 to 5, characterized in that: The following steps are involved: S1, the midgut tissue of the 5th instar 3-day-old silkworm F7 strain was taken to extract total RNA, and then the total RNA was used as a template to synthesize cDNA by reverse transcription; S2. The CDS sequence of the BmCXE-26 gene was synthesized using cDNA as a template, wherein the forward primer for cloning the CDS sequence was shown in SEQ ID NO:4, and the reverse primer was shown in SEQ ID NO:

5.

7. Use of the BmCXE-26 gene and its regulatory sequence according to any one of claims 1 to 5 as a molecular marker for silkworm resistance to pyrethroid insecticides.

8. Use of the BmCXE-26 gene and its regulatory sequence according to any one of claims 1 to 5 as a molecular breeding target for silkworm resistance to pyrethroid insecticides.

9. An expression vector comprising the BmCXE-26 gene and its regulatory sequence according to any one of claims 1 to 5.

10. A host cell comprising the expression vector of claim 9.